According to the Biotechnology Innovation Organisation, BioTech is “technology based on biology – harness[sing] cellular and biomolecular processes to develop technologies and products that help improve our lives and the health of our planet.” More than just a tool for human health, BioTech is involved in many industries including energy and fuel, and agriculture and food, where innovations in the field helps address some of the world’s most pressing issues.
Big Pharmas are not the only players, BioTech startups are bringing their cutting-edge technologies out of the labs, making a stab at these global issues and succeeding. As with the many diverse types of Deep Tech startups, the entrepreneurial scientists in the BioTech fields face the age-old challenge – recruiting teams with specialised expertise and funding, as well as unique problems such as access to essential wet lab facilities. In the current uncertain climate, these challenges are intensified, how are these startups pulling through and overcoming the hurdles?
Discover from our panel of life science entrepreneurs and investors in Singapore as they discuss the BioTech landscape, what BioTech means to human health, the roadblocks to conquer and advice to budding BioTech startups and entrepreneurial life-science researchers.